Introduction
Beta-blockers 1,2 have gained a remarkable place worldwide to treat several cardiovascular disorders such as hypertension, angina pectoris, cardiac arrhythmia, and open angle glaucoma. 3, 4 Beta-blockers also demonstrate efficacy to control adolescent and childhood disorders such as migraine headaches, dysrhythmias, anxiety, and behavioral disorders.
5
Increased systolic and diastolic blood pressure can cause hypertension, which then can damage the renal, cardiac, and brain blood vessels. 6 Beta-blockers block the action of the sympathetic nervous system of the heart, thus reducing stress on the heart. Beta-blockers block beta-adrenergic substances such as epinephrine (adrenaline) in the autonomic nervous system. They control the increase in blood pressure and thus inhibit the damage to blood vessels. 3, 4, 7 Beta-blockers are incorporated in a wide range of clinical applications because they block the adverse effects of catecholamines on β -adrenergic receptors.
8
Most of the racemic beta-blocker drugs are effective because their (S) -enantiomer shows great structural similarities to the adrenergic hormone noradrenaline, whereas the (R) -enantiomer is responsible mostly for side effects. 9,10 (S)-betaxolol (1) 8 ( Figure 1 ) demonstrates beta-blocking activity as a strong antiglaucoma agent.
11−13
Metoprolol (2) ( β 1 -blockade of catecholamines) ( Figure 1 ) is widely used in the treatment of angina and hypertension.
14 Metoprolol shows great potential to treat sympathetic nervous system disorders. Modified and derived drugs of metoprolol are emphasized 15, 16 due to their rapid elimination and low oral bioavailability. Sotalol (3) (Figure 2 ) is most effective in reentrant verticular arrhythmia and belongs to class III of antiarrythmic drugs. 18−21 These drugs also have applications in the treatment of asthma, bronchitis, and congestive heart failure. 22 The l -enantiomer of sotalol demonstrates 20 times more beta-blocker activity as compared to d− enantiomer.
23,24
Figure 2. Structures of sotalol and timolol beta-blockers.
Timolol (4) (Figure 2 ) (or amphiphilic prodrugs such as nadolol 25 ) has also been found to be effective in hypertension and angina pectoris. 26, 27 When administrated to the eyes, timolol exhibits the capability to lower intraocular pressure, which is the base of its use to treat glaucoma. 28 
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Synthesis of betaxolol
Considering the significance of beta-blockers, Manoury et al. 29 explained the synthesis of betaxolol by selective benzylation of phenolic alcohol of 4-hydroxyphenethanoic acid. Reduction of the ethanoic acid group was followed by alkylation with (bromomethyl)cyclopropane. Deprotection with H 2 followed by treatment with isopropylamine furnished the betaxolol.
In continuation of their previous work, Manoury et al. 30 prepared pharmacologically active betaxolol.
(S)-(-)-2-phenyl-3-isopropyl-5-(hydroxylmethyl)oxazolidinyl tosylate (6) was used for the alkylation of phenol 5. 31 The resulting product 7 after acid-catalyzed hydrolysis afforded the ( S) enantiomer of 1. Compound 5
was also allowed to react with (2 R)-3-(tosyloxy)-1,2-propanediol acetonide 8 32 followed by hydrolysis. The resulting diol 9 was tosylated and converted to epoxide 10. Treatment of epoxide 10 with isopropylamine furnished the (R) enantiomer of 1 (Scheme 1).
In order to check the drug metabolism, protein binding ability, and pharmacokinetics, Allen and Tizot 33 incorporated tritium in betaxolol, which exhibited high specific activity. Synthesis was initiated from the bromination of 4-[2-(cyclopropylmethoxy)ethyl]phenol, an intermediate employed for the preparation of betaxolol.
29,30
The product 2,6-dibromo phenol (11) was alkylated using excess epichlorohydrin under basic conditions to afford epoxypropane (12) . Treatment of epoxypropane 12 with excess of isopropylamine at 100
• C in a bomb In view of the advancements in synthetic methodologies for beta-blockers, Ippolito and Vigmond
39−41
described a number of protection/deprotection syntheses of betaxolol. 4-Hydroxyphenethanol (19) was converted to phenoxide anion using a base followed by reaction with epichlorohydrin. The yielded product 1-[4-(2-hydroxyethyl)phenoxy]2,3-epoxypropane was treated with primary amine to provide the betaxolol intermediate.
To obtain the product, protection and deprotection were the necessary steps.
Protection and deprotection increase the synthetic steps, which lowers the yield. Wang et al. was obtained when compound 10 was reacted with isopropylamine followed by the addition of HCl (Scheme 6). Hydrolytic kinetic resolution (HKR), the simplest approach for enantioselective preparation of stereoisomers, has attracted considerable attention from researchers. Joshi et al. 44 utilized the said approach to synthesize ( S)-betaxolol in enantiomerically pure form. Benzylation of 2-(4-hydroxy phenyl) ethanol (19) in the presence of phase transfer catalyst at ambient temperature resulted in 90% yield of regioselective product Oalkylated 2-(4-benzyloxyphenyl)ethanol (21) . Condensation of 21 with allyl bromide resulted in 1-(2-allyloxyethyl)-4-benzyloxy benzene (22) (98% yield). Furukawa modification of the Simmon-Smith reaction was utilized for the cyclopropanation of the olefinic part of compound 22 to afford compound 23 (95% yield). Debenzylation of compound 23 followed by allylation provided compound 24 via 5, which on further treatment with mCPBA in DCM under ambient conditions afforded epoxide 10. Due to the fluidity of epoxide 10, it was incorporated in the HKR approach. Using Jacobsen catalyst ( Figure 3 ) and water at room temperature, HKR was performed 10 (43% yield, 99% ee) and ( R)-diol 9 (47% yield, 92% ee) was carried out over silica gel. HPLC using chiral column CHIRALCEL OD was used to determine enantiomeric excess (ee). The epoxide 10 was allowed to react with i−PrNH 2 at ambient temperature, which furnished crude (S)-betaxolol. Pure (S)-betaxolol in 99%
ee was obtained after silica gel column chromatography (Scheme 7). Alternatively, 45 
Scheme 7. Preparation of ( S) -betaxolol (1).
In another methodology, Joshi et al. 46 selectively allylated the alcoholic group of 5 to afford 4-(2-allyloxy-ethyl)phenol (25) followed by the reaction of (R)-(-)-epichlorohydrin with phenol 25. The afforded intermediates 26 and 27 were then subjected to ring opening reactions with i− PrNH 2 in the presence of a base to furnish ( S) -(-)-1-{4-[2-(allyloxy)-ethyl]phenoxy} -3-isopropylamino propan-2-ol (28) . The SimmonSmith reaction converted the amino alcohol 28 to the requisite betaxolol (1) (Scheme 8).
Scheme 8. Synthesis of ( S) -betaxolol from compound 5.
Datta et al. 47 synthesized betaxolol via Heck arylation of vinyl ethers (Scheme 9). Synthesis was started from a cheaper reagent. p -chloronitrobenzene (29a). Palladium-catalyzed transvinylation of cyclopropylmethanol and ethyl vinyl ether using 2,2 ' -bipyridyl ligand resulted in the formation of cyclopropylmethylvinyl ether (30c). Compound 32 (60% yield) in highly regioselective coupling was prepared using Heck arylation in aqueous DMF (Method A). The hydrogenation of the olefinic bond and nitro group of 32 furnished compound 33 (79% yield). Aryl chloride 29a was also converted directly in one step to 33 in greater yield.
Treatment of 33 with sodium nitrite (diazotization) and water resulted in phenol 5 (50% yield). Reaction of (R)-3-isopropylamine 1,2-epoxypropane and then refluxing in ethanol for 8 h provided active (S) -betaxolol.
Treatment with dry HCl (gas) in dry ether and crystallization afforded (S) -1.HCl (Scheme 10).
The envisioned efficacy of HKR encouraged Muthukrishnan et al. 48 to employ this approach for the concise synthesis of (S)-betaxolol. Reaction of 2-(4-hydroxyphenyl)ethanol (19) (47% yield, 92% ee) was achieved when hydroxyl group of ( S) -epoxide 34 was selectively O− alkylated using chloromethylcyclopropane in the presence of KOt-Bu. Treatment of (S)-epoxide 10 with excess N -isopropyl amine and refluxing for 2-10 h provided (S) -betaxolol. Silica gel column chromatography was then performed to purify the crude ( S)-betaxolol (1) (96% yield, 99% ee) (Scheme 11). was treated with bromomethyl cyclopropane to give a pale yellow oil, which was mixed with 10% HCl and then extracted with EtOAc to afford the 1.HCl. Treatment with 10% NaOH followed by recrystallization from ether provided concerned (S)-1 (yield 95%, ee > 99%) (Scheme 13).
Scheme 12. Synthesis of C-12 higher carbon sugar.
Scheme 13. Synthesis of betaxolol from compound 36.
Due to the efficiency of the enzymatic kinetic resolution approach, Li et al. 50 developed a novel approach that was more economical and stereoselective, for the direct resolution of betaxolol enantiomers and its analogues. De-acetylation by enzyme catalyst was employed for kinetic resolution to afford (S) -betaxolol. A biocatalyst, the strain Rhodotorula mucilaginosa obtained from soil, was used for kinetic resolution of substrates 39 and 15 (acetylated intermediates). The lipase in the strain was highly selective for (R)-enantiomers.
(S)-betaxolol was obtained directly by chemical methods from the corresponding intermediates. This method proved to be economical and highly stereoselective (Scheme 14).
Scheme 14. Chemoenzymatic synthesis of ( S)− betaxolol.
In connection with their previous work, Li et al. 51 synthesized ( S)− betaxolol by chemoenzymatic approach. Betaxolol after N , O -bisacetylation was also subjected to hydrolysis by different strains. Two out of 52 strains catalyzed the hydrolysis significantly but exhibited low selectivity. Alternatively compound 39 was prepared from 19. The complete kinetic resolution of 39 was performed to get the desired intermediates. Phodotorula mucilaginosa DQ832198 showed better ee and enantioselectivity factor. To get better yield and high yield, ( S) -1, afterN , O -bisacetylation, was subjected twice to kinetic resolution for 12 h. Intermediates were converted to (S )-1.HCl (98% yield, 95% ee). 52 Recrystallization using Et 2 O enhanced the ee to 99% (Scheme 15). Synthesis and characterization of hydrochloride of betaxolol were carried out by Xu and Fang. 53 Selective
Williamson etherification between epichlorohydrin and p -hydroxy phenylethyl alcohol using 18% K 2 CO 3 -acetone alkalescent solution was carried out to synthesize (1-[4-(2-Hydroxyethyl)phenoxy]-2,3-epoxypropane], a betaxolol hydrochloride intermediate.
Synthesis of metoprolol
The metabolism of metoprolol takes place through oxidative pathways. Gurjar et al. 61 presented an efficient and novel synthetic approach for the preparation of racemic metoprolol. Phenol 52 was subjected to modified Friedel-Crafts acylation 62 using chloroacetylchloride to achieve 2-chloro-1-(4-hydroxyphenyl) ethanone (53) The use of novel and rapid instruments in the synthetic approach is always encouraged. Svensson et al.
76
employed modern techniques, Raman spectroscopy, and chemometrics to monitor the metoprolol synthesis. Epoxide 57 was heated with isopropylamine in the presence of isopropanol. The reaction mixture was heated applying a temperature gradient to produce 2.
Enantioselectivity and the facile availability of materials is always a major requirement of the pharmaceutical industries. Jung et al. 52 described the asymmetric synthesis of metoprolol and related metabolites.
Treatment of phenolic compounds 50, 64, and 65 with methanolic sodium hydroxide followed by the addition of (R) and (S)-epichlorohydrin provided the 2,3-epoxypropoxy (R) and (S) enantiomers 57, 66, and 67, respectively, which were further converted to the target compounds 2, 68, and 69. Hydrolysis of 69 using KOH and methanol (1:1) afforded the compound 70. Compound 70 was isolated and characterized as potassium salt after neutralization. The enantiomers of 70 were also prepared by reacting 65 with epichlorohydrin enantiomers using excess triethylamine instead of NaOH. Optical purities of all enantiomers were determined by HPLC (Scheme 22).
Scheme 22. Synthesis of metoprolol and its metabolites.
The cardiovascular activity of metoprolol derivatives inspired Melgar-Fernandez et al. 77 for the synthesis of metoprolol analogues. Four novel stereoisomeric metoprolol derivatives carrying two stereogenic centers were synthesized. The two diastereotopic methyl groups in metoprolol were converted into an alkyl group and alkyl hydroxyl group. The synthetic route was started from the preparation of 4-(2-methoxyethyl) phenol (50) using The envisioned efficacy of hydrolytic kinetic resolution method (KHR) encouraged Muthukrishnan et al. 48 to utilize it for the concise synthesis of ( S)-metoprolol incorporating 2-(4-hydroxy-phenyl) ethanol (19) as the starting reagent. Treatment of intermediate ( S)-epoxide 34 with methyl iodide followed by the addition of i-propylamine afforded the crude (S)-metoprolol hydroiodide salt 74. Moreover, 6% ammonia solution was used to free the crude ( S) -metoprolol hydroiodide salt. Silica gel column chromatography was performed to purify the crude (S)-metoprolol 2 (97% yield, 96% ee) (Scheme 24).
Scheme 24. Synthesis of metoprolol from ( S) -34.
Use of chiral auxiliary HCS for the kinetic resolution by Zhang et al. 49 was developed for the synthesis of ( S)-metoprolol. The starting reagent 50 was converted to metoprolol as described earlier (Scheme 25). The use of the chiral building blocks inspired Sonawane et al. 82 to report a short synthetic strategy for the asymmetric synthesis of ( S)-metoprolol manipulating chiral building block (2S ,2 ′ S ,2" S) -Tris-(2,3-epoxypropyl)-isocyanurate (S-TGT). 83 Treatment of S-TGT with phenol 50 afforded pure oxazolidine 76.
(S)-N -alkylated oxazolidine (77) was achieved by reacting 76 with isopropyl bromide in NaH. Base hydrolysis of 77 afforded the desired (S) -metoprolol in quantitative yield (Scheme 28).
Cheng et al. 84 reported the enantioselective synthesis of metoprolol under Sharpless asymmetric dihydroxylation. The process was performed using polymer ligand QN-AQN-gmnnOPEG-OMe, which could easily be recovered. The synthesis started from the base catalyzed nucleophilic attack of phenol 50 on the allyl bromide in dry acetone. The obtained compound 54 (87% yield) was subjected to asymmetric dihydroxylation with the help of K 2 OsO 2 (OH) 4 , QN-AQN-OPEG-OMe using co-oxidants K 3 Fe(CN) 6 and K 2 CO 3 in a t -BuOH/H 2 O system. Extraction with DCM, diethyl ether incorporation, and filtration afforded the QN-AQN-OPEG-OMe (95%). The obtained diol (S)-55 (96% ee) was subjected to epoxidation using trimethylorthoacetate, PPTS, and AcBr in the presence of K 2 CO 3 . The synthesized epoxide on treatment with isopropylamine was converted to ( S)-metoprolol (2) (62% yield, 91% ee) (Scheme 29).
Scheme 28. Synthesis of ( S) -metoprolol using S-TGT.
Scheme 29. Synthetic route of ( S) -metoprolol 2.
Synthesis of sotalol
The concise synthesis of d-sotalol was presented by Smith et al. 85 employing homogeneous chiral hydrogena- and subsequently protection of the hydroxyl group using TESCl afforded iodosilyl ether (86) Refluxing of 89 with i-PrNH 2 in THF was carried out. Upon the completion of the reaction, the reaction mixture was treated with 20% H 2 SO 4 followed by 20% NaOH to achieve nifenalol (90) (61% yield, enantiomeric purity 96%). Chiral β -hydroxy propylamine (90) For the first time enzymatic resolution effort was adopted by Kamal et al. 98 for the synthesis of both enantiomers of sotalol. Reaction of aniline 92 with methane sulfonyl chloride in DCM and subsequent treatment with chloroacetyl chloride provided the ketone 79. One pot reduction of 79 and then enzymatic resolution of racemic chlorohydrins was the main step in this protocol. Reduction was performed using NaBH 4 and moist neutral aluminum oxide in diisopropyl ether. Resolution of chlorohydrins was carried out in situ by transesterification using immobilized Pseudomonas cepacia lipase (PS-C) and isopropyl acetate (acyl donor).
The resolved alcohol (-)-81 (90% ee) and acetate (+)-93 (94% ee) were treated with i -PrNH 2 to achieve the sotalol (-)-3 (90% ee) and (+)-3 (94% ee) (Scheme 34).
For the facile synthesis of sotalol, Kapoor et al. nipulated, initiated by the reduction of 95 using NaBH 4 /MeOH to achieve (±)-96. Racemic alkyl acyl esters 97a-c were stereoselectively hydrolyzed by a number of lipases/estereases (Scheme 36). The enantiopurity was not improved by this approach for the hydrolyzed products. Commercial enzyme CRL hydrolyzed the butyl ester 97c (60% ee, 47% conversion), while the Arthrobecter sp. provided better selectivity (75% ee) for the acetate. Effectiveness of co-solvent to improve selectivity was also checked. Transesterification was also performed using different estereases. PS-C-II as a catalyst with vinyl acetate (acyl donor) and solvent provided the best results. In order to improve the transesterification reaction by PS-C-II in a short time, various solvents were employed. Transesterification proved to be the most effective for the resolution of 96 racemic mixture under optimum conditions (PS-C-II, 200 g/L conc., toluene). Toluene improved the reaction rate, afforded the efficient resolution and complete conversion in a short time (Scheme 37). To overcome the deficiency of easily available reagents, Blay et al. 100 adopted the highly stereoselective Henry reaction to afford ( S) -(+)-sotalol using appropriate aldehyde. The main feature of this synthesis is the Henry reaction, which produced the desired nitro alcohol in high ee using aminopyridine copper complex (98) . 
Synthesis of timolol
Utilizing optically active precursors, Weinstock et al. 31 carried out the synthesis of timolol. In the first step, In order to enhance the ocular delivery of timolol, Bundgaard et al. 106 synthesized timolol prodrugs.
Esters of timolol were also evaluated for their hydrolysis kinetics and lipophilicity. After maintaining suitable pH and extraction of timolol maleate, excess of 3 M HCl in methanol was added to get timolol hydrochloride. Slurry of timolol hydrochloride was prepared in benzene and then treated with appropriate acid chloride. Separation of timolol esters (110-113) was also carried out (Scheme 44).
In continuation of their previous work, Bundgaard et al. 107 reported the synthesis of different substituted timolol esters and checked their stability and lipophilicity. Some timolol esters in the form of their hydrochlorides were prepared as reported earlier. 106 Using the same methodology, the hydrochloride salt of O -isobutyryl ester was also prepared and isolated. Reaction of timolol maleate and corresponding acid chloride in acetonitrile resulted in the formation of all other esters as fumarate salts except two. After slurry formation of timolol 
Conclusion
The synthetic/medicinal value of beta-blockers is well-known. The synthetic approaches attempted so far towards the synthesis of beta-blockers (betaxolol, metoprolol, sotalol, and timolol) have been summarized in this article. It is evident that the synthesis of beta-blockers can be achieved by different pathways. This article is especially useful for scientists/chemists interested in the synthesis of analogues of beta-blockers.
